Syndax Announces Participation in September Investor Conferences

Rhea-AI Summary

Syndax Pharmaceuticals (NASDAQ: SNDX), a commercial-stage biopharmaceutical company focused on innovative cancer therapies, has announced its participation in two upcoming investor conferences in September 2025.

CEO Michael A. Metzger and the management team will present at Citi's 2025 BioPharma Back to School Conference on September 2 at 4:45 p.m. ET and the H.C. Wainwright 27th Annual Global Investment Conference on September 8 at 9:00 a.m. ET. Both presentations will be available via webcast on the company's investor relations website.

NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer, as well as members of the Syndax management team, will participate in the following upcoming investor conferences:

• Citi’s 2025 BioPharma Back to School Conference with a fireside chat on Tuesday, September 2, 2025, at 4:45 p.m. ET.
• H.C. Wainwright 27^th Annual Global Investment Conference with a company presentation on Monday, September 8, 2025, at 9:00 a.m. ET.

A live webcast of these sessions will be available in the Investor section of the Company's website at www.syndax.com, where a replay will also be available for a limited time.

About Syndax

Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company's pipeline include Revuforj^® (revumenib), an FDA-approved menin inhibitor, and Niktimvo™ (axatilimab-csfr), an FDA-approved monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment. For more information, please visit www.syndax.com or follow the Company on X and LinkedIn.

Syndax Contacts
Sharon Klahre
Syndax Pharmaceuticals, Inc.
sklahre@syndax.com
Tel 781.684.9827

SNDX-G

FAQ

When is Syndax (SNDX) presenting at the Citi BioPharma Conference 2025?

Syndax will present at Citi's BioPharma Conference on Tuesday, September 2, 2025, at 4:45 p.m. ET in a fireside chat format.

Who will represent Syndax Pharmaceuticals at the September 2025 investor conferences?

CEO Michael A. Metzger and members of the Syndax management team will represent the company at the conferences.

How can investors access Syndax's (SNDX) conference presentations?

Investors can access the live webcasts and replays of the presentations through the Investor section of Syndax's website at www.syndax.com.

What time is Syndax's presentation at the H.C. Wainwright Conference?

Syndax will give a company presentation at the H.C. Wainwright Conference on Monday, September 8, 2025, at 9:00 a.m. ET.